Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1051

1.

The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.

Klapproth K, Sander S, Marinkovic D, Baumann B, Wirth T.

Blood. 2009 Sep 17;114(12):2448-58. doi: 10.1182/blood-2008-09-181008. Epub 2009 Jul 23.

2.
4.
5.

c-Myc sensitizes cells to tumor necrosis factor-mediated apoptosis by inhibiting nuclear factor kappa B transactivation.

You Z, Madrid LV, Saims D, Sedivy J, Wang CY.

J Biol Chem. 2002 Sep 27;277(39):36671-7. Epub 2002 Jul 30.

7.

Nfkb 1 is dispensable for Myc-induced lymphomagenesis.

Keller U, Nilsson JA, Maclean KH, Old JB, Cleveland JL.

Oncogene. 2005 Sep 15;24(41):6231-40.

PMID:
15940251
8.

Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha/c-myc transgenic mice.

Factor V, Oliver AL, Panta GR, Thorgeirsson SS, Sonenshein GE, Arsura M.

Hepatology. 2001 Jul;34(1):32-41.

PMID:
11431731
9.

Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.

Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, Sakr WA, Raz A.

Mol Cancer Ther. 2007 Oct;6(10):2757-65. Epub 2007 Oct 3.

11.

c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.

Biliran H Jr, Banerjee S, Thakur A, Sarkar FH, Bollig A, Ahmed F, Wu J, Sun Y, Liao JD.

Clin Cancer Res. 2007 May 1;13(9):2811-21.

12.

Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis.

Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY.

Oncogene. 2004 Nov 18;23(54):8731-42.

PMID:
15480428
13.
14.

Up regulation of GW112 Gene by NF kappaB promotes an antiapoptotic property in gastric cancer cells.

Kim KK, Park KS, Song SB, Kim KE.

Mol Carcinog. 2010 Mar;49(3):259-70. doi: 10.1002/mc.20596.

PMID:
19908244
15.

CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.

Hirsch B, Hummel M, Bentink S, Fouladi F, Spang R, Zollinger R, Stein H, Dürkop H.

Am J Pathol. 2008 Feb;172(2):510-20. doi: 10.2353/ajpath.2008.070858. Epub 2008 Jan 10.

16.
17.

Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway.

Kuo PL, Hsu YL, Lin TC, Tzeng WS, Chen YY, Lin CC.

Cancer Lett. 2007 Apr 18;248(2):280-91. Epub 2006 Sep 11.

PMID:
16963181
18.

Pectenotoxin-2 abolishes constitutively activated NF-kappaB, leading to suppression of NF-kappaB related gene products and potentiation of apoptosis.

Kim MO, Moon DO, Heo MS, Lee JD, Jung JH, Kim SK, Choi YH, Kim GY.

Cancer Lett. 2008 Nov 18;271(1):25-33. doi: 10.1016/j.canlet.2008.05.034. Epub 2008 Jul 3.

PMID:
18602210
19.

Myc suppression of Nfkb2 accelerates lymphomagenesis.

Keller U, Huber J, Nilsson JA, Fallahi M, Hall MA, Peschel C, Cleveland JL.

BMC Cancer. 2010 Jul 2;10:348. doi: 10.1186/1471-2407-10-348.

20.

Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53.

Han SS, Chung ST, Robertson DA, Ranjan D, Bondada S.

Clin Immunol. 1999 Nov;93(2):152-61.

PMID:
10527691

Supplemental Content

Support Center